ProfileGDS4718 / 209198_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 10% 16% 61% 14% 18% 21% 23% 18% 12% 9% 13% 25% 20% 17% 32% 20% 21% 24% 16% 43% 19% 20% 10% 9% 16% 20% 10% 11% 12% 19% 13% 38% 20% 12% 35% 30% 13% 23% 15% 69% 14% 25% 58% 20% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8116510
GSM549102patient 115, normal, homogenized [OPG study]3.9954916
GSM549104patient 119, normal, homogenized [OPG study]6.2086461
GSM549108patient 138, normal, homogenized [OPG study]3.9579214
GSM549119patient 077, normal, homogenized [OPG study]4.0560518
GSM549133patient 032, cancer, homogenized [OPG study]4.1228721
GSM549139patient 042, cancer, homogenized [OPG study]4.2394623
GSM549099patient 107, normal, homogenized [OPG study]4.0864318
GSM549109patient 139, normal, homogenized [OPG study]3.8885112
GSM549110patient 046, normal, homogenized [OPG study]3.73069
GSM549114patient 063, normal, homogenized [OPG study]3.8764313
GSM549122patient 082, normal, homogenized [OPG study]4.3529525
GSM549134patient 033, cancer, homogenized [OPG study]4.1300420
GSM549136patient 036, cancer, homogenized [OPG study]3.9915817
GSM549140patient 044, cancer, homogenized [OPG study]4.5755332
GSM549111patient 047, normal, homogenized [OPG study]4.1126220
GSM549113patient 057, normal, homogenized [OPG study]4.1203121
GSM549132patient 031, cancer, homogenized [OPG study]4.2978324
GSM549137patient 038, cancer, homogenized [OPG study]3.9895916
GSM549142patient 047, cancer, homogenized [OPG study]5.2735843
GSM549100patient 110, normal, homogenized [OPG study]4.1300819
GSM549107patient 135, normal, homogenized [OPG study]4.1245920
GSM549115patient 068, normal, homogenized [OPG study]3.7398810
GSM549116patient 072, normal, homogenized [OPG study]3.74439
GSM549120patient 078, normal, homogenized [OPG study]4.0095316
GSM549131patient 030, cancer, homogenized [OPG study]4.1102720
GSM549118patient 074, normal, homogenized [OPG study]3.7893910
GSM549129patient 027, cancer, homogenized [OPG study]3.839111
GSM549123patient 088, normal, homogenized [OPG study]3.8471212
GSM549124patient 006, cancer, homogenized [OPG study]4.1460219
GSM549126patient 015, cancer, homogenized [OPG study]3.8799613
GSM549128patient 025, cancer, homogenized [OPG study]4.8915238
GSM549103patient 117, normal, homogenized [OPG study]4.1690420
GSM549117patient 073, normal, homogenized [OPG study]3.8647912
GSM549138patient 041, cancer, homogenized [OPG study]4.7299535
GSM549141patient 045, cancer, homogenized [OPG study]4.4798330
GSM549130patient 028, cancer, homogenized [OPG study]3.9122313
GSM549101patient 111, normal, homogenized [OPG study]4.2781123
GSM549105patient 128, normal, homogenized [OPG study]3.9763115
GSM549106patient 134, normal, homogenized [OPG study]6.8751669
GSM549112patient 048, normal, homogenized [OPG study]3.9282714
GSM549125patient 011, cancer, homogenized [OPG study]4.3480825
GSM549127patient 024, cancer, homogenized [OPG study]6.0148458
GSM549135patient 035, cancer, homogenized [OPG study]4.1109220